# Partially reversible bilateral non-arteritic anterior ischemic optic neuropathy and branch retinal artery occlusion following semaglutide use. a case report.

> PubMed lists PMID 42432542 in BMC ophthalmology as Journal Article, with publication-date metadata of 2026-07-10 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42432542-semaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-10
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42432542-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42432542-semaglutide-v1.json
- Content SHA-256: `6ec5d64106c007ff83d0e8826b9c078ff4d074945575324a93eb60ef766585c3`

## Claims and source pins

### Headline

Partially reversible bilateral non-arteritic anterior ischemic optic neuropathy and branch retinal artery occlusion following semaglutide use. a case report. ([`pubmed-observation-pmid-42432542-2026-07-10-5adc8b896313`](#source-pubmed-observation-pmid-42432542-2026-07-10-5adc8b896313))

### Summary

PubMed lists PMID 42432542 in BMC ophthalmology as Journal Article, with publication-date metadata of 2026-07-10 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42432542-2026-07-10-5adc8b896313`](#source-pubmed-observation-pmid-42432542-2026-07-10-5adc8b896313))

### Paragraph 1

PubMed lists PMID 42432542 in BMC ophthalmology as Journal Article, with publication-date metadata of 2026-07-10 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42432542-2026-07-10-5adc8b896313`](#source-pubmed-observation-pmid-42432542-2026-07-10-5adc8b896313))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42432542-2026-07-10-5adc8b896313`](#source-pubmed-observation-pmid-42432542-2026-07-10-5adc8b896313))

## Sources

<a id="source-pubmed-observation-pmid-42432542-2026-07-10-5adc8b896313"></a>
- **Partially reversible bilateral non-arteritic anterior ischemic optic neuropathy and branch retinal artery occlusion following semaglutide use. a case report. · retained source version 1:2026-07-10:current:5adc8b896313640a52fb7fe92599f2cde17d398f9a9118b41f8407a5eef5af9b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42432542/) (`pubmed-observation-pmid-42432542-2026-07-10-5adc8b896313`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Partially reversible bilateral non-arteritic anterior ischemic optic neuropathy and branch retinal artery occlusion following semaglutide use. a case report." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42432542-semaglutide-v1.json SHA-256: 6ec5d64106c007ff83d0e8826b9c078ff4d074945575324a93eb60ef766585c3.